Legaspi, Hannilore V.

HRN: 04-64-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2022
CEFUROXIME 1.5GM (VIAL)
06/06/2022
06/07/2022
IV
1.5g
Q8 X 3 Doses
S/P NSVD With Episiorrhaphy Of 4th Degree Laceration
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: